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Letter to the Editor
Categorization  of  dengue  fever  according  to phase  of
illness—a suggestion  for  clinical  studies  using  single
[PDI]. A patient with PDI will demonstrate NS1 antigen till the
3rd  day of illness (sometimes as long as the 9th day), IgM anti-diagnostic sample
Dear Editor,
In  2008, World Health Organization (WHO) experts agreed
that  “dengue is one disease entity with different clinical pre-
sentations  and often with unpredictable clinical evolution
and  outcome”.1 The development of a spectrum of labo-
ratory  methods to detect the ﬁrst of seven non-structural
proteins in dengue virus, NS1 (non-structural protein-1) leads
us  toward an opportunity to observe the features of dengue
during  viremic phase which corresponds to the ﬁrst 3 days
of  illness.1 Prior to the availability of NS1 antigen assays for
detection  of dengue, the illness was  conﬁrmed only after the
detection  of IgM and (or) IgG antibodies. This also helps us
infer  that studies on dengue fever using positive serology as
part  of dengue case deﬁnition would have identiﬁed only fea-
tures  of dengue in the immune phase of the illness. Though
inference based on paired sera is the ideal way to conﬁrm
dengue, our limited experience in dengue indicates that the
concept  of utilizing paired sera in dengue diagnosis is difﬁcult
to  practice since obtaining a sample beyond the 10th day of
Table 1 – Laboratory based staging for clinical studies using a s
Phase of illness Primary infection 
Viremic NS1 positive 
Viremia-immune
overlap
NS1 positive 
Plus 
One of the following: 
IgM  positive (>40 units) and IgG negative 
IgM/IgG optical density ratio > cut-off value
Immune IgM  positive (>40 units) and IgG negative 
OR
IgM/IgG optical density ratio > cut-off value
IgM and IgG detection by enzyme-linked immunosorbent assay (ELISA). N
a Studies have used a cut-off value of 1.2 with patient sera in 1/100 dilutioillness in a patient who is free of symptoms raises consent
related issues.2,3 WHO  recommends classiﬁcation of dengue
as  dengue fever ± warning signs and severe dengue.1 We  sug-
gest  a further laboratory based categorization for dengue
illness  (both WHO  categories) using a single diagnostic sample
incorporating aspects related to dengue pathogenesis.
A brief overview on the immunology of dengue may  help
in  understanding our classiﬁcation.1,4 Dengue fever is charac-
terized  by an initial viremic phase which corresponds to the
ﬁrst  3 days of illness followed by immune phase (also called
critical  phase) spanning from 3rd to 6th day of illness. The
phase  of dengue beyond 6th day of illness is called recov-
ery  phase (though a sizable number of patients take longer
to  recover). When the dengue virus infects a previously non-
infected  person, it is inferred as primary dengue infectioningle diagnostic sample.
Secondary infection
No isolated viremic phase since anamnestic
IgG response often present at the onset of
illness
NS1 positive
Plus
One of the following
IgG positive (>100 units) and IgM negative
 of assaya IgM/IgG optical density ratio < cut-off value of
assaya
IgM/IgG optical density ratio < cut-off value of
assaya
 of assaya
S1 detection by ELISA (further scientiﬁc inputs required).
n or 1.4 with patient sera in 1/20 dilution.5
bodies  detectable beyond the 3rd day of illness and IgG beyond
the  7th day of illness. Though IgM and IgG are detectable by
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he 7th day of PDI, the dominant antibody is IgM as demon-
trated  by IgM/IgG optical density ratio of more  than the assay
ut-off  value (studies have used a cut-off value of >1.2 with
atient  sera in 1/100 dilution or >1.4 with patient sera in 1/20
ilution).5 When the dengue virus infects a person who had
een  previously infected by a different dengue serotype it is
aid to be secondary dengue infection [SDI]. The detection of
S1  in SDI is timed similar to PDI. However an anamnestic
gG  response occurs at the onset of SDI earlier to the appear-
nce  of IgM antibodies making the onset of the immune phase
oncomitant  with the viremic phase. The challenge in identi-
ying  SDI is complicated by two factors. First, a slow IgM rise
sometimes  not detectable) during convalescence in SDI. Sec-
nd, IgG is being the dominant antibody in SDI. These make
gM/IgG  optical density ratio less than the assay dependent
ut-off value as a laboratory hallmark of SDI. Though serial
onitoring of IgG titers helps in SDI diagnosis, the concept is
nfrequently practised. Studying dengue illness after catego-
izing  it as viremic phase, viremia-immune overlap phase, and
mmune  phase (Table 1) will facilitate better understanding of
ccurrence  and progression of clinical symptoms, signs and
aboratory  ﬁndings. Obtaining these information (especially
ourse  of thrombocytopenia and organ dysfunction) gains crit-
cal importance since it may  help us predicting the course of
he  illness with current therapies for dengue fever.
The  suggested classiﬁcation may  furthermore help iden-
ifying  the effects of interventions (anti-viral therapy,
orticosteroids, immunosuppresants) during viremic phase
nd  viremia-immune overlap which could lessen the compli-
ations  observed in the immune phase. The classiﬁcation does
ave important limitations. First one is the diagnosis of SDI,
 factor which is difﬁcult to address taking into account the
omplex  IgM and IgG antibody response observed in secondary
nfection.  Second is the lack of standardization among NS1
ssays,  though an ELISA based protocol is generally preferred.6
HO  recommendation on methods of NS1 detection will add
larity to the classiﬁcation. Third, diagnostic accuracy com-
ared  to paired sample. Adopting a cut-off value for IgM
>40  units) and IgG (>100 units) in the classiﬁcation has par-
ially  addressed the non-inclusion of paired sera for dengue
iagnosis.7onﬂict  of  interest
he authors declare no conﬂicts of interest.3;1 7(5):622–623  623
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